Follow
Mark Slee
Mark Slee
College of Medicine and Public Health, Flinders University of South Australia
Verified email at flinders.edu.au - Homepage
Title
Cited by
Cited by
Year
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
13262013
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
8462019
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Data analysis: Bahlo Melanie 2 Brown Matthew A 6 7 Browning Brian L 20 ...
Nature genetics 41 (7), 824-828, 2009
5322009
Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis
JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ...
Jama 321 (2), 175-187, 2019
4612019
Defining secondary progressive multiple sclerosis
J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ...
Brain 139 (9), 2395-2405, 2016
3922016
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci
NA Patsopoulos, ...
Annals of neurology 70 (6), 897-912, 2011
3602011
Geographical variations in sex ratio trends over time in multiple sclerosis
M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ...
PloS one 7 (10), e48078, 2012
2612012
Predictors and dynamics of postpartum relapses in women with multiple sclerosis
SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ...
Multiple Sclerosis Journal 20 (6), 739-746, 2014
2042014
Defining reliable disability outcomes in multiple sclerosis
T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ...
Brain 138 (11), 3287-3298, 2015
2012015
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, ...
Brain 136 (12), 3609-3617, 2013
1952013
Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS
KA Ribbons, P McElduff, C Boz, M Trojano, G Izquierdo, P Duquette, ...
PloS one 10 (6), e0122686, 2015
1922015
Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis
T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ...
Annals of Neurology 77 (3), 425-435, 2015
1862015
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
T Kalincik, JWL Brown, N Robertson, M Willis, N Scolding, CM Rice, ...
The Lancet Neurology 16 (4), 271-281, 2017
1712017
Fingolimod after natalizumab and the risk of short-term relapse
VG Jokubaitis, V Li, T Kalincik, G Izquierdo, S Hodgkinson, R Alroughani, ...
Neurology 82 (14), 1204-1211, 2014
1552014
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis
KS Gandhi, FC McKay, M Cox, C Riveros, N Armstrong, RN Heard, ...
Human molecular genetics 19 (11), 2134-2143, 2010
1502010
Multifocal motor neuropathy: the diagnostic spectrum and response to treatment
M Slee, A Selvan, M Donaghy
Neurology 69 (17), 1680-1687, 2007
1442007
Incidence and prevalence of NMOSD in Australia and New Zealand
W Bukhari, KM Prain, P Waters, M Woodhall, MOG Cullen, L Clarke, ...
Journal of Neurology, Neurosurgery & Psychiatry 88 (8), 632-638, 2017
1182017
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
T Kalincik, A Manouchehrinia, L Sobisek, V Jokubaitis, T Spelman, ...
Brain 140 (9), 2426-2443, 2017
1142017
Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist. ANZgene Consortium. GeneMSA. International Multiple Sclerosis Genetics Consortium Genome-wide meta …
NA Patsopoulos
Ann Neurol 70 (6), 897-912, 2011
1122011
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
I Kister, T Spelman, R Alroughani, J Lechner-Scott, P Duquette, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (10), 1133-1137, 2016
1042016
The system can't perform the operation now. Try again later.
Articles 1–20